Aldehyde dehydrogenase activity selects for the holoclone phenotype in prostate cancer cells

Biochemical and Biophysical Research Communications

Volumn 414, Issue 4, 2011, Pages 801-807

  Doherty, R E ^a   Haywood Small, S L ^a   Sisley, K ^b   Cross, N A ^a  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Aldehyde dehydrogenase; Cancer stem cells; Prostate cancer; Stem cell hierarchy

Indexed keywords

ALDEHYDE DEHYDROGENASE;

ARTICLE; CANCER CELL; CANCER STEM CELL; CELL ADHESION; CELL CLONE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HOLOCLONE; HUMAN; HUMAN CELL; MALE; PARACLONE; PHENOTYPE; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; STEM CELL; TUMOR SPHEROID;

CELL ADHESION; CELL PROLIFERATION; CLONE CELLS; COLONY-FORMING UNITS ASSAY; CULTURE MEDIA; HUMANS; ISOENZYMES; MALE; NEOPLASTIC STEM CELLS; PHENOTYPE; PROSTATIC NEOPLASMS; RETINAL DEHYDROGENASE; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 80555122771     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.10.010     Document Type: Article

References (34)

1. Reya T., Morrison S., Clarke M., Weissman L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
2. Tan B.T., Park C.Y., Ailles L.E., Weissman L. The cancer stem cell hypothesis: a work in progress. Lab. Invest. 2006, 86:1203-1207.
3. Li H., Tang D.G. Prostate cancer stem cells and their potential roles in metastasis. J. Surg. Oncol. 2011, 103:558-562.
4. Clevers H. The cancer stem cell: premises, promises and challenges. Nat. Med. 2011, 313-319.
5. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997, 3:730-737.
6. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, et al., Prospective identification of tumorigenic breast cancer cells, Proc. Natl. Acad. Sci. USA 100 (2003) 3983-3988.
7. Collins A.T., Berry P.A., Hyde C., et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65:10946-10951.
8. Bertolini G., Roz L., Perego P., et al. Highly tumorigenic lung cancer CD133 cells display stem-like features and are spared by cisplatin treatment. Proc. Natl. Acad. Sci. USA 2009, 106:16281-16286.
9. Singh S.K., Clarke I.D., Terasaki M., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63:5821-5828.
10. O'Brien C.A., Pollett A., Gallinger S., Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2006, 445:6-110.
11. Hess D.A., Meyerrose T.E., Wirthlin L., et al. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 2004, 104:1648-1655.
12. Ginestier C., Hur M.H., Charafe-Jauffret E., et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1:555-567.
13. Corti S., Locatelli F., Papadimitriou D., et al. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 2006, 24:975-985.
14. Yoshida A., Rzhetsky A., Hsu L.C., Chang C. Human aldehyde dehydrogenase gene family. Eur. J. Biochem. 1998, 251:549-557.
15. Chute J.P., Muramoto G.G., Whitesides J., et al. Inhibition of aldehyde dehydrogenase and retinoid signalling induces the expansion of human hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 2006, 103:11707-11712.
16. Ma I., Allan A.L. The role of human aldehyde dehydrogenase in normal and cancer stem cells. SCRR 2010, 7:1-15.
17. van den Hoogen C., van der Horst G., Cheung H., et al. High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res. 2010, 70:5163-5173.
18. Jiang F., Qiu Q., Khanna A., et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol. Cancer Res. 2009, 7:330-338.
19. Kryczek I., Liu S., Roh M., et al. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. Int. J. Cancer 2011, 10:1-11.
20. Barrandon Y., Green H. Three clonal types of keratinocyte with different capacities for multiplication. Proc. Natl. Acad. Sci. USA 1987, 84:2302-2306.
21. Claudinot S., Nicolas M., Oshima H., et al. Long-term renewal of hair follicles from clonogenic multipotent stem cells. Proc. Natl. Acad. Sci. USA 2005, 102:14677-14682.
22. Locke M., Heywood M., Fawell S., Mackenzie I.C. Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res. 2005, 65:8944-8950.
23. Felthaus O., Ettl T., Gosau M., et al. Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell lines. Biochem. Biophys. Res. Commun. 2011, 407:28-33.
24. Li H., Chen X., Calhoun-Davis T., et al. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res. 2008, 68:1820-1825.
25. Zhang K., Waxman D.J. PC3 prostate tumor-initiating cells with molecular profile FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesis. Mol. Cancer 2010, 9:319-332.
26. Guzmán-Ramírez N., Völler M., Wetterwald A., et al. In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue. Prostate 2009, 69:1683-1693.
27. Chinzei R., Tanaka Y., Shimizu-Saito K., et al. Embryoid-body cells derived from a mouse embryonic stem cell line show differentiation into functional hepatocytes. Hepatology 2002, 36:22-29.
28. D.B. Ou, Y. He, R. Chen, et al., Three-dimensional co-culture facilitates the differentiation of embryonic stem cells into mature cardiomyocytes. J. Cell. Biochem. 2011, doi:10.1002/jcb.23283.
29. Shirasawa S., Yoshie S., Yue F., et al. Pancreatic exocrine enzyme-producing cell differentiation via embryoid bodies from human embryonic stem cells. Biochem. Biophys. Res. Commun. 2011, 410:608-613.
30. Wicha M.S., Liu S., Dontu G. Cancer stem cells: an old idea-a paradigm shift. Cancer Res. 2006, 66:1883-1890.
31. Prasmickaite L., Engesaeter B., Skrbo N., et al. Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma. PLOS One 2010, 5:1-12.
32. Cross N.A., Waterman E.A., Jokonya N., et al. Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells. J. Cell. Biochem. 2008, 104:1452-1464.
33. Dontu G., Abdallah W.M., Foley J.M., et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003, 17:1253-1270.
34. Reynolds B.A., Weiss S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev. Biol. 1996, 175:1-13.